Logo
ホームページ
当社のモデルを探求してください。
カート
連絡先
購読する
モデル製品
HUGOシリーズ 🌟
HUGO-GT™(ヒト化ゲノムオルソログ)
HUGO-Ab™(抗体開発)
HUGO-Mab™ – 完全ヒトモノクローナル抗体マウス
MouseAtlas モデルライブラリ
期間限定セール
研究用動物モデル
Creマウス系統
ヒト化ターゲット遺伝子モデル
代謝疾患モデル
眼科疾患モデル
神経疾患モデル
自己免疫疾患モデル
免疫不全マウスモデル
ヒト化免疫系マウスモデル
腫瘍学・免疫腫瘍学モデル
新型コロナウイルス感染症(Covid-19)用マウスモデル
細胞株モデル
ノックアウト細胞株製品カタログ
iPS細胞株製品カタログ
腫瘍細胞株製品カタログ
AAV 标準製品カタログ
サービス
前臨床薬効評価
神経科学
アルツハイマー病前臨床CROサービス
パーキンソン病前臨床CROサービス
ハンチントン病前臨床CROサービス
血液脳関門(BBB)研究ソリューション
眼科分野
緑内障前臨床CROサービス
加齢黄斑変性(AMD)前臨床CROサービス
がん研究
PBMCヒト化マウスモデル
ヒト免疫システム(HIS)マウスモデル
代謝・循環器系疾患
抗肥満薬開発向け前臨床CROサービス
自己免疫・炎症疾患
喘息前臨床CROサービス
遺伝子改変動物
ノックアウトマウス
トランスジェニックマウス
ノックインマウス
ノックアウトラット
ノックインラット
トランスジェニックラット
遺伝子改変モデルの作製技術
TurboknockoutTMゲノム標的化技術
ターゲティング遺伝子編集
通常型トランスジェニック
PiggyBacトランスジェネシス
BACトランスジェニック
ES細胞ターゲティング
繁殖・サポートサービス
繫殖サービス
凍結保存および回復
表型解析サービス
BAC改変
ウイルスパッケージング
アデノ関連ウイルス(AAV)パッケージング
レントウイルスパッケージング
アデノウイルスパッケージング
カスタム細胞株作製サービス
誘導多能性幹細胞(iPS細胞)
ノックアウト細胞株
ノックイン細胞株
点変異細胞株
過剰発現細胞株
モダリティ
遺伝子治療
AI駆動型AAV開発
核酸医薬
細胞免疫療法
コミュ二ティー
キャンペーン
イベント・ウェビナー
ニュース
研究情報
資料室
データベース
査読済み文献(引用)
希少疾患データセンター
AbSeek
Cell iGeneEditor™ システム
OriCell 細胞培養関連
会社案内
企業概要
施設概要
動物の健康・福祉
健康報告書
協力企業・代理店
採用情報
お問い合わせ
Login
フィルター
フィルター
KO/cKO マウスモデル
フラッシュセール
HUGO-GT™ プラットフォーム
ヒト化ターゲット遺伝子モデル
ヒト化ターゲット遺伝子モデル
免疫ターゲットヒト化モデル腫瘍ターゲットヒト化モデル代謝ターゲットヒト化モデルサイトカインヒト化モデルその他のターゲットヒト化モデル
免疫系マウスモデル
免疫不全マウスモデルヒト化免疫系モデル
遺伝学ツールマウスモデル
Creドライバー系統レポーターマウス系統その他の遺伝学ツール系統
専門疾患モデル
眼科疾患モデル神経疾患モデル代謝疾患モデル腫瘍学・免疫腫瘍学モデル自己免疫疾患モデル希少疾患モデル感染症疾患モデルその他の疾患モデル
7 件の結果が “11304” で取得されました
フィルター
並べ替える:
アルファベット順(A-Z)
ベストセラー
Abca4-KO
製品ID :
C002024
系統:
C57BL/6JCya
状況:
Live Mouse
説明:
Stargardt disease (STGD), a hereditary macular dystrophy, is characterized by the presence of yellowish flecks within the retinal pigment epithelium (RPE), ultimately culminating in macular atrophy. Typically manifesting in childhood and adolescence, STGD leads to progressive central vision loss and mild dyschromatopsia. Fundoscopic examination may reveal pale yellow lesions exhibiting a characteristic gold foil-like sheen, accompanied by yellow-white spots surrounding the posterior pole. In advanced stages, atrophy of the RPE, photoreceptors, and choriocapillaris is observed. This bilateral and typically synchronous condition affects both eyes with comparable incidence across sexes, estimated between 1/8,000 and 1/13,000. STGD is predominantly an autosomal recessive disorder, with mutations in the ABCA4 gene accounting for approximately 95% of cases. ABCA4 encodes a retina-specific ABC transporter protein crucial for the clearance of retinal derivatives and toxic metabolites generated during rhodopsin photobleaching. Consequently, ABCA4 mutations result in the accumulation of these cytotoxic substances, triggering apoptosis of both RPE and photoreceptor cells and ultimately driving retinal degeneration. Notably, ABCA4 mutations have been implicated in a spectrum of retinal diseases, including STGD, cone-rod dystrophy (CRD), age-related macular degeneration (AMD), and retinitis pigmentosa (RP), with the specific clinical phenotype correlating with the nature and severity of the ABCA4 mutation. This strain is an Abca4 gene knockout (KO) mouse model. Gene-editing technology was used to delete the protein-coding sequence of the Abca4 gene (the homolog of the human ABCA4 gene) in mice. Previous studies have demonstrated that Abca4 KO mice exhibit delayed dark adaptation following photobleaching and a slow progression of photoreceptor degeneration[1]. Homozygous Abca4-KO mice are viable and fertile.
Stargardt disease (STGD), a hereditary macular dystrophy, is characterized by the presence of yellowish flecks within the retinal pigment epithelium (RPE), ultimately culminating in macular atrophy. Typically manifesting in childhood and adolescence, STGD leads to progressive central vision loss and mild dyschromatopsia. Fundoscopic examination may reveal pale yellow lesions exhibiting a characteristic gold foil-like sheen, accompanied by yellow-white spots surrounding the posterior pole. In advanced stages, atrophy of the RPE, photoreceptors, and choriocapillaris is observed. This bilateral and typically synchronous condition affects both eyes with comparable incidence across sexes, estimated between 1/8,000 and 1/13,000. STGD is predominantly an autosomal recessive disorder, with mutations in the ABCA4 gene accounting for approximately 95% of cases. ABCA4 encodes a retina-specific ABC transporter protein crucial for the clearance of retinal derivatives and toxic metabolites generated during rhodopsin photobleaching. Consequently, ABCA4 mutations result in the accumulation of these cytotoxic substances, triggering apoptosis of both RPE and photoreceptor cells and ultimately driving retinal degeneration. Notably, ABCA4 mutations have been implicated in a spectrum of retinal diseases, including STGD, cone-rod dystrophy (CRD), age-related macular degeneration (AMD), and retinitis pigmentosa (RP), with the specific clinical phenotype correlating with the nature and severity of the ABCA4 mutation. This strain is an Abca4 gene knockout (KO) mouse model. Gene-editing technology was used to delete the protein-coding sequence of the Abca4 gene (the homolog of the human ABCA4 gene) in mice. Previous studies have demonstrated that Abca4 KO mice exhibit delayed dark adaptation following photobleaching and a slow progression of photoreceptor degeneration[1]. Homozygous Abca4-KO mice are viable and fertile.
Abca4/Rdh8-DKO
製品ID :
C001968
系統:
C57BL/6JCya
状況:
Live Mouse
説明:
The Abca4/Rdh8-DKO mouse is a dual-gene knockout model obtained by mating Rdh8-KO mice (catalog No.: C001969) with Abca4-KO mice (catalog No.: C002024). This model can be used to investigate the pathogenic mechanisms and therapeutic strategies of diseases, including Stargardt disease (STGD) and age‑related macular degeneration (AMD), and facilitates the evaluation of synergistic effects of polygenic therapies.
The Abca4/Rdh8-DKO mouse is a dual-gene knockout model obtained by mating Rdh8-KO mice (catalog No.: C001969) with Abca4-KO mice (catalog No.: C002024). This model can be used to investigate the pathogenic mechanisms and therapeutic strategies of diseases, including Stargardt disease (STGD) and age‑related macular degeneration (AMD), and facilitates the evaluation of synergistic effects of polygenic therapies.
Abca4-KO
製品ID :
S-KO-20307
系統:
C57BL/6JCya
状況:
Frozen Sperm
説明:
Abca4 is located on chromosome 3 of mice. Nuclease Technology was used to design sgRNA; Abca4 knockout mice were obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Abca4 is located on chromosome 3 of mice. Nuclease Technology was used to design sgRNA; Abca4 knockout mice were obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Abca4-KO
製品ID :
S-KO-00815
系統:
C57BL/6NCya
状況:
Frozen Sperm
説明:
Abca4 is located on chromosome 3 of mice. Nuclease Technology was used to design sgRNA; Abca4 knockout mice were obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Abca4 is located on chromosome 3 of mice. Nuclease Technology was used to design sgRNA; Abca4 knockout mice were obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Rhox10-flox
製品ID :
S-CKO-11304
系統:
C57BL/6JCya
状況:
Research and Development
説明:
Rhox10 is located on chromosome X of mice. SgRNA and ssDNA will be designed using Nuclease Technology; Rhox10 conditional knockout mice will be obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm will be collected for cryopreservation.
Rhox10 is located on chromosome X of mice. SgRNA and ssDNA will be designed using Nuclease Technology; Rhox10 conditional knockout mice will be obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm will be collected for cryopreservation.
Zfp800-KO
製品ID :
S-KO-11304
系統:
C57BL/6JCya
状況:
Research and Development
説明:
Zfp800 is located on chromosome 6 of mice. Nuclease Technology will be used to design sgRNA; Zfp800 knockout mice will be obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Zfp800 is located on chromosome 6 of mice. Nuclease Technology will be used to design sgRNA; Zfp800 knockout mice will be obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Abca4-flox
製品ID :
S-CKO-00932
系統:
C57BL/6JCya
状況:
Frozen Sperm
説明:
Abca4 is located on chromosome 3 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Abca4 conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Abca4 is located on chromosome 3 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Abca4 conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Items: 1 to 7 of 7
1
さらに
すべてのフィルター
Strain Type
Mouse
Rat
Modification Type
Knockout
Conditional Knockout
Knockin
Point Mutation
Transgenic
Conditional Knockin
Others
Status
Live Mice
R&D
Frozen Sperm
Validation Data
Verified
In Progress
リセット
確認する
モデルライブラリ
モデルライブラリ
リソース
リソース
動物の品質
動物の品質
サポートを受ける
サポートを受ける
住所:
〒543-0071 大阪府大阪市天王寺区生玉町2-3 小出ビル410室
電話 :
06-7652-3321
メール:
[email protected]
モデル製品
HUGO-Ab™(抗体開発)HUGO-GT™(ヒト化ゲノムオルソログ)MouseAtlas モデルライブラリ研究用動物モデル
サービス
神経科学眼科分野がん研究代謝・循環器系疾患自己免疫・炎症疾患
会社案内
企業概要施設概要動物の健康・福祉健康報告書協力企業・代理店採用情報お問い合わせ
SNS
免責事項:当社の製品およびサービスの価格や入手可能性は地域によって異なります。記載されている価格は特定の国々に適用されます。詳細についてはご連絡ください。
Copyright © 2025 Cyagen. All rights reserved.
プライバシーポリシー
サイトマップ
Cyagenの最新情報をお届けします
研究モデル、CROサービス、科学リソース、特別オファーに関する最新情報を、研究ニーズに合わせてメールでお届けします。
お名前
メール
ご所属機関
関心分野
主な研究分野